Anemia Drug, Erythropoietin, May Prevent Cerebral Palsy Linked to Hypoxia During Birth
A Phase 2 clinical trial revealed that the drug erythropoietin, long used to treat anemia, might improve outcomes for children exposed to oxygen deprivation during birth, leading to hypoxic-ischemic encephalopathy — brain damage that causes cerebral palsy and other disabling conditions. If the findings stand through larger trials, the treatment might offer…